Chapter 28: Skeletal Muscle & Peripheral Nerve Pathology

Welcome to Last Minute Lecture.

This free chapter overview is designed to help students review and understand key concepts.

These summaries supplement not replaced the original textbook and may not be redistributed or resold.

For complete coverage, always consult the official text.

Welcome back to the Deep Dive.

Today, we are focusing our lens on a system that, I mean, it literally moves us through the world.

It's the machinery of movement itself.

Exactly.

We're talking muscle and nerve.

Specifically, we are cracking open Chapter 28 of the USMLE Step 1 Lecture Notes, Pathology, the 2017 edition.

It's a chapter that covers skeletal muscle and peripheral nerve pathology.

And I think for a lot of students, or even just people interested in human biology, this is an area that can sometimes get glossed over.

We tend to focus on the big organs, the heart, the lungs, the brain, but the apparatus that actually executes the brain's commands is incredibly complex and frankly pretty fragile.

That's what stood out to me as I was prepping for this.

You really start to realize how many precise molecular handshakes have to happen just for me to lift my coffee mug.

And when those handshakes fail, the pathology is just devastating.

So our mission today is very, very specific.

We're going to walk through this chapter from start to finish.

We aren't skipping the tables.

We aren't skipping the microscopic descriptions.

And we are certainly not skipping the Y.

Not at all.

Exactly.

The goal isn't to just memorize that disease X has symptom Y.

I mean, that's superficial.

We want to understand the mechanism.

Yes.

Why does the immune system attack the muscle in one disease, but the nerve in another?

Why do certain tumors look the way they do under a microscope?

If we can build that logical framework, you'll find the facts to stick.

And just a quick ground rule for everyone listening.

We are sticking strictly to the text provided in Chapter 28.

We aren't wandering off into other textbooks or bringing in outside treatments unless they're explicitly in these notes.

No.

We want to give you a pure high yield download of exactly what is in the source material.

Focus is the name of the game today.

So let's start where the chapter starts.

Before we can talk about things breaking, we have to talk about how they work.

Section one, the physiology of movement, specifically the muscle fiber types.

Right.

This is the tale of two fibers.

You might think muscle is just muscle, but at a cellular level, that's not true at all.

The text breaks this down into type I and type two fibers and table 28 to one does a great job of contrasting them.

OK, let's look at type I first.

The text calls these red fibers.

Let's unpack that color.

Why are they red?

Well, it's not a dye.

It's pure biology.

They are red because they are just packed with myoglobin.

Myoglobin.

OK, so that's like hemoglobin, but in muscle.

Exactly.

It's a protein that binds to oxygen.

And on top of that, these fibers are also packed with mitochondria, the power plants of the cell.

I see.

So that combination of iron rich protein and dense organelles, it gives the tissue a dark red appearance.

And I guess form follows function here because they have all that oxygen binding capacity and all this mitochondria.

What is their primary job?

Endurance, pure and simple.

The text lists their function as postural weight bearing and sustained tension.

So like the muscles in my back right now keeping me upright in this chair.

Exactly.

Or the muscles in your legs when you're standing in line.

They have to work for hours at a time without stopping.

They can't afford to get tired.

So there's slow twitch.

Precisely.

They're slow twitch, meaning they don't contract explosively, but they are slow to fatigue.

And how do they fuel that marathon effort?

What's the energy source?

They rely on aerobic metabolism.

That's why they need all those mitochondria to run the Krebs cycle.

And their fuel of choice,

fatty acids.

Fatty acids.

Yeah, fatty acids provide a really high yield of ATP and are a long lasting fuel source.

It's a slow, steady, efficient burn.

Okay, so type I is the marathon runner.

Red, slow twitch, aerobic, uses fatty acids and is packed with mitochondria.

Now let's look at the other side of the coin, type II fibers.

These are the white fibers.

And just from the name you can probably guess the difference.

They have very little myoglobin and very few mitochondria.

So they aren't built for the long haul.

Not at all.

No, they are built for power.

Their function is purposeful movement and short, quick bursts.

Like sprinting for a bus.

Exactly.

This is used sprinting to catch a bus or lifting a heavy box off the floor.

You need a massive amount of force and you need it instantly.

But the trade off is fatigue.

Right, they fatigue rapidly.

Because they don't use oxygen and fatty acids efficiently, they have to rely on anaerobic glycolysis.

Meaning they burn sugar.

They burn stored glycogen.

It's like dumping lighter fluid on a fire.

You get a huge flare up of energy, but it burns out really, really quickly.

So type II is the sprinter.

White, fast twitch, anaerobic, burns glycogen and has very few mitochondria.

Exactly.

And there's one more sentence in this section that I think is the most important concept for understanding all the pathology we're about to see.

OK.

The text states,

skeletal muscle fiber type is determined by innervation.

Determined by innervation.

Wow.

So that implies the muscle doesn't decide its own destiny.

It absolutely doesn't.

The nerve tells the muscle what to be.

If a slow twitch nerve connects to a bundle of fibers, those fibers become type I.

That's incredible.

It is.

If you were to experimentally cut that nerve and attach a fast twitch nerve,

the muscle would actually remodel itself to become type II.

The nerve is the master.

The muscle is the servant.

That is a profound point because it means if you have a disease of the nerve, you're inevitably going to see changes in the muscle.

They are inextricably linked.

You can't separate them.

Correct.

And that is a perfect transition into our next section.

Yeah.

We know how the muscle is supposed to work.

Now let's look at what happens when the body starts attacking it.

Section two, inflammatory myopathies.

So this is a group of autoimmune diseases where the immune system gets confused and targets its own muscle tissue.

The text outlines three specific conditions here.

Polymyositis, dermatomyositis, and inclusion body myositis.

Right.

Let's take them one by one.

First up, polymyositis.

Polymyositis.

Poly means many.

Myositis means muscle inflammation.

The typical patient here is an adult.

And the presentation is very, very specific.

The text describes it as bilateral proximal muscle weakness.

We're going to hear proximal a lot today.

So let's define that clearly for everyone listening.

Good call.

Proximal means closest to the center of the body.

So we were talking about the shoulder girdle and the pelvic girdle, so your hips.

We're not talking about the hands or feet.

That would be distal.

So these patients struggle with big movements.

They can't lift their arms up over their head.

Exactly.

They have trouble combing their hair.

They've troubled standing up from a low chair or climbing stairs because their hip muscles are weak.

And bilateral means it's symmetrical.

Both shoulders, both hips.

Now here is where the pathology gets really high yield.

If we take a biopsy of that weak muscle, what are we seeing under the microscope?

In polymyositis, the inflammation is described as endomyceal.

Endomyceal.

OK, let's visualize the muscle structure.

You have the whole muscle, which is made of these bundles called fascicles.

And inside the fascicles, you have the individual muscle fibers.

And endo means inside.

So in polymyositis, the inflammatory cells are invading inside the fascicle surrounding the individual muscle fibers.

It's a very deep, intimate attack.

And who are the attackers?

What kind of cells are these?

The text specifies cytotoxic T8 lymphocytes.

These are the killer T cells.

They are directly damaging the muscle fibers, which leads to necrosis cell death and then regeneration.

OK, so for polymyositis, we're thinking adults, proximal weakness, endomyceal inflammation, and T8 cells.

End treatment.

Well, because it's a direct autoimmune attack by T cells, it usually responds well to immunosuppression, like corticosteroids.

Got it.

Now, let's contrast that with the second condition,

dermatomyositis.

As the name implies, this one has a skin component, vermito.

And unlike polymyositis, which is mostly in adults,

dermatomyositis can affect both children and adults.

The muscle symptoms are similar, though, right?

Yes, the weakness pattern is the same.

Bilateral and proximal.

Shoulders and hips.

But the patient also walks in with these very distinct skin findings.

The text mentions a heliotrope rash.

That is such a specific, almost poetic name.

It is.

It refers to the color of the heliotrope flower, which is this vivid purple.

The text describes this as a purple or red rack on the upper eyelids.

And it comes with swelling.

It's often accompanied by periorbital edema, which just means swelling around the eyes.

So if you have a patient with swollen, violet eyelids and weak shoulders, that is a classic, classic presentation.

The text also mentions redness and scaling.

But that eyelid rash is the key.

That's the money shot.

Now, let's go back to the microscope.

Remember, polymyositis was endomyceal inside the bundle.

Right.

Dermatomyositis is paramyceal.

Paramyceal.

So the inflammation is in the paramecium.

Correct.

The paramecium is the connective tissue wrapper that surrounds the fascicle, the whole bundle.

The inflammation is primarily in that wrapper and around the blood vessels within it.

And I'm guessing this location matters for the pattern of damage.

It absolutely does.

Because the inflammation is on the outside of the bundle,

the muscle fibers that are closest to that edge get hurt first.

The text calls this para -physicular fiber atrophy.

Ah.

So the fibers on the periphery of the bundle shrink.

The atrophy, yeah.

It's a great visual.

That is a great visual.

Polymyositis is inside the house.

Dermatomyositis is surrounding the house.

That's the way to remember it.

Now there's a very, very serious warning in the text regarding dermatomyositis, especially in adults.

The clinical note.

Yes.

Adult patients with dermatomyositis have an increased risk of malignancy.

We are talking lung cancer, colon cancer, breast cancer, gynecologic cancers.

So the muscle disease is essentially a perineoplastic syndrome.

It's a side effect of a hidden cancer.

Exactly.

It's a huge red flag.

If you diagnose an adult with dermatomyositis, your job isn't done.

You have to go hunting for the underlying tumor.

That is a life -saving distinction.

The text also mentions a specific antibody for these myopathies.

Yeah, the anti -tRNA synthetase antibodies.

The most famous one listed is anti -JO1.

If you see anti -JO1, it's a strong, strong marker for inflammatory myopathy.

OK, we've done poly and germido.

Now for the third one, which seems to be the odd one out.

Inclusion body myositis.

Yeah, this one breaks all the rules we just set up.

First, the demographic's different.

It affects adults over the age of 50.

Second, the distribution of weakness is completely different.

Instead of proximal, it is distal weakness.

So we're talking about hands and feet.

And instead of being bilateral and symmetrical, it is often asymmetrical.

It has a huge difference.

Proximal and bilateral for the first two, distal and asymmetrical for IBM.

Exactly.

And microscopically, it has a unique feature, hence the name inclusion body myositis.

You see autophagic vacuoles and inclusion bodies in the cytoplasm of the muscle cells.

Autophagic vacuoles?

That sounds like the cell is eating itself.

That is literally what it means.

It's degenerative process happening alongside the inflammation.

And because it's degenerative and not just purely autoimmune, the treatment response is poor.

The text explicitly says it is refractory to immunosuppressive therapy.

So steroids don't really fix it?

No, which makes an accurate diagnosis crucial so you don't blast an elderly patient with high dose steroids for no reason.

Right.

Okay, that wraps up the inflammatory myopathies.

Let's move down the chain of command.

We've looked at the muscle tissue itself.

Now let's look at the connection point, the neuromuscular junction, section three,

myasthenic syndromes.

The neuromuscular junction or NMJ.

This is the synapse where the nerve talks to the muscle.

Figure 28 to two in the text gives us a great schematic of this.

So let's visualize it for the listeners.

Okay, set the scene for us.

We have the nerve terminal on one side.

Right, the presynaptic membrane and the muscle membrane on the other, the postsynaptic membrane.

And between them is a gap.

The synaptic cleft.

And the whole goal is to get a signal across that gap.

The nerve does this by releasing a chemical messenger,

acetylcholine or HE.

So the nerve spits out acetylcholine into the gap.

The HE floats across and binds to acetylcholine receptors on the muscle side.

When enough HE binds, it opens up ligand gated channels, sodium rushes in and the muscle contracts.

Simple enough, but in myasthenia gravis, this system fails.

Myasthenia gravis is an autoimmune disease.

The body produces autoinibodies that specifically target the HE receptor on the muscle.

So the messenger, the HE is there, but the mailbox, the receptor is being destroyed.

Exactly.

The antibodies block the receptors and trigger their degradation.

So the muscle simply cannot receive the signal to contract.

Who typically gets this?

The text says females are affected more frequently than males and the clinical presentation is absolutely classic.

Facial muscle weakness.

Yes.

The muscles of the face and eyes are small and they work constantly.

So they are often the first to show signs.

You see the ptosis, which is drooping eyelids and diplopia or double vision.

And there is a key characteristic to this weakness, right?

It's not static.

No, not at all.

It features fatigue ability.

The weakness worsens with repeated contractions.

Explain the mechanism behind that.

Why does it get worse with use?

Okay, so in a normal person, every time a nerve fires, it releases slightly less HE than the time before.

But we have so many extra receptors, it's called a safety factor, that it doesn't matter.

We have a buffer.

We have a huge buffer.

In myasthenia gravis, you have very few receptors left.

So when the HE levels drop even a little bit with repeated use, the signal fails.

There's no buffer.

So if you ask a patient to look up at the ceiling for 30 seconds, their eyelids will slowly start to droop because they're just running out of signal strength.

That's exactly it.

That is the bedside test.

And the real danger here is, if this fatigue hits the respiratory muscles, the text warns that respiratory involvement can lead to death.

Is there an anatomical culprit we can go after?

Something we can target?

Yes, the thymus gland.

The text lists thymic hyperplasia, which is enlargement, and thymomas, which are tumors, as key associations.

So a thymectomy, removing the thymus, is often part of the treatment.

It is, along with anti -cholinesterase agents, which keep the AC around longer in the cleft.

Ah, to give it more time to find one of the few remaining receptors.

Right, if you have fewer mailboxes, you wanna flood the zone with as many letters as possible.

Now let's compare that to the other syndrome in this section, Lambert -Eaton myasthenic syndrome.

This is a fascinating contrast.

Lambert -Eaton is also autoimmune, but the target is on the other side of the gap.

The antibodies attack the presynaptic calcium channels on the nerve terminal itself.

Okay, we need to recall our physiology here.

What does calcium do in the nerve terminal?

Calcium is the trigger.

When the electrical signal hits the nerve end, calcium channels open, calcium rushes in, and that influx of calcium causes the vesicles to release acetylcholine.

So if you block the calcium channels, you never release the acetylcholine.

The signal dies before it even leaves the nerve.

And the context for this disease is usually cancer, right?

Yes, it's a classic perineoplastic syndrome.

The text notes it frequently arises before malignancy is diagnosed.

And the culprit is usually small cell lung cancer.

Clinically, how do we tell this apart from myasthenia gravis?

Two main clues.

One, patients often have dry mouth, which is autonomic dysfunction along with their proximal weakness.

And two, and this is the big one,

the weakness improves with use.

Improves.

That's the complete opposite of myasthenia gravis.

It is, it's called the warm -up phenomenon.

As you repetitively stimulate the nerve, you force more and more calcium into the terminal through the few working channels.

Eventually, you build up enough calcium to trigger a release of AC.

So the patient actually gets stronger as they move.

For a short time, yes.

That is such a crucial distinction.

Fatigability versus the warm -up, postsynaptic versus presynaptic.

And treatment involves immunotherapy, and most importantly,

finding and treating that underlying lung cancer.

All right, moving on to section four.

Muscular dystrophies.

We are leaving the world of autoimmunity and entering the world of genetics.

These are structural failures of the muscle cell itself.

The text focuses on the two big ones.

Duchenne and Becker.

Muscular dystrophies.

Both are X -linked recessive disorders.

X -linked recessive.

Okay, so this means it predominantly affects males.

Correct.

The mother is usually a carrier.

She has one good X chromosome and one bad one, but her son inherits the bad X and has no backup.

And the gene at fault here is for the dystrophin protein.

Right, the dystrophin gene, located at XP21.

What is dystrophin?

Why is it so important?

The text describes it as a structural protein.

Think of a muscle cell as a machine with moving parts inside, the actin and myosin, and a shell on the outside, the cell membrane.

Dystrophin is the anchor.

It connects the inside machinery to the outside shell.

It stabilizes the cell membrane during the force of contraction.

So if you don't have that anchor.

The membrane is unstable.

Every single time the muscle contracts, the membrane tears.

This leads to calcium leaks into the cell, enzyme leaks out of the cell, and eventually the cell dies.

Let's talk about Duchenne muscular dystrophy first.

This is the more severe form.

In Duchenne, the mutation results in a virtual absence of dystrophin.

The body makes almost none of it.

It's a complete failure of the protein.

And the clinical course reflects that severity.

It does.

The boys are typically normal at birth, but the onset of symptoms happens by age five.

It is a rapidly progressive disease of degeneration.

There are two physical signs the text highlights.

The first is calf pseudohypertrophy.

This is such a tragic sign.

Pseudohypertrophy means false enlargement.

The calves look big and bulky.

You might think the child is building muscle.

But they're not.

But in reality, the muscle fibers are dying and being replaced by fat and connective tissue.

So it's big, but it's weak.

Exactly.

It's all fatty infiltration and fibrosis.

The second sign is the gaur sign.

Figure 28 to three illustrates this.

Can you describe what is happening in that image?

It demonstrates that profound proximal muscle weakness, especially in the pelvic girdle.

The child is trying to stand up from the floor, but his hip extensors, his glutes, and his quads are too weak to lift his torso.

So he has to find another way.

He has to compensate.

So he plants his feet, puts his hands on the floor, and then walks his hands back towards his feet and then literally up his own legs.

He climbs up himself.

Yes, he uses his arms to push his torso upright because his legs just can't do it.

That is the gaur sign.

And what are the complications that eventually lead to mortality here?

The heart is a muscle and it also relies on dystrophin.

So heart failure and arrhythmias are very common.

Also respiratory insufficiency.

The text notes that decreased mucociliary clearance and weak respiratory muscles lead to pneumonia and other pulmonary infections.

How do we confirm the diagnosis, labs or biopsy?

Both.

Labs will show massively elevated serum creatine kinase or CK.

CK is an enzyme that lives inside muscle cells.

When the cells tear open, it leaks into the blood.

And the biopsy?

A biopsy will show variation in fiber size,

necrosis, and that fatty replacement we talked about.

But the definitive test is an immunostain, which will show the absence of the dystrophin protein.

Now briefly, let's mention Becker muscular dystrophy.

Becker is the milder cousin.

It's the same gene dystrophin, but the mutation is different.

Instead of a mutation that results in an absence of the protein, it creates an altered dystrophin.

So they have a protein that's just not perfect.

Right, it works, but not well.

Because they have some function, the onset is later, the progression is much slower, and patients can live a relatively normal lifespan.

Cardiac involvement is also much rarer.

It really shows how the specific type of genetic mutation, a deletion versus just an alteration, can dictate the entire life of the patient.

A stark example, absolutely.

We are making great time.

Let's shift gears.

We've covered muscle, we've covered the junction.

Now let's look at the nerves themselves.

Section five, inflammatory neuropathy.

And the big topic here, the main one in the text, is Guillain -Barre syndrome.

This is a name you hear in the news sometimes, usually associated with vaccines or outbreaks.

But what is the actual pathology?

It is an acute, life -threatening, autoimmune demyelinating disorder.

The immune system attacks the Schwann cells.

And Schwann cells are the ones that make the myelin sheath in the peripheral nervous system.

Correct, they are the insulation on the wire.

If you strip the insulation, the electrical signal slows down dramatically, or just stops altogether.

What triggers this attack?

The text notes it is usually preceded by a viral illness.

So the patient has a flu or a stomach bug like Campylobacter, they recover.

And then a few weeks later, the neurological symptoms start.

And the direction of the symptoms is key.

It is, it presents with ascending paralysis.

Ascending, so it starts at the bottom and goes up.

Yes,

weakness and loss of deep tendon reflexes start in the legs and move up to the trunk and then the arms.

And the danger, obviously, is if it keeps ascending.

Right, if it reaches the phrenic nerve in the diaphragm, you have respiratory paralysis.

The text notes it is fatal in about 5 % of cases for this reason.

These patients often need to be intubated and put on a ventilator until the inflammation subsides.

How do we diagnose it?

Well, nerve conduction studies will show that it's slowing because of the demyelination.

But the classic lab finding is in the cerebrospinal fluid, the CSF.

From a lumbar puncture, a spinal tap.

Exactly, the CSF shows elevated protein.

Just elevated protein.

What about white blood cells?

Isn't there inflammation?

That's the trick.

The text emphasizes elevated protein, but typically the cell count is normal.

This is called albuminocytologic dissociation.

Okay, what does that mean?

It just means the protein from the inflamed nerve roots leaks into the fluid.

But the white blood cells don't necessarily flood the CSF itself.

High protein, normal cells.

And treatment.

It's supportive care, but also plasmapheresis, which is filtering the blood to remove antibodies and intravenous immunoglobulin therapy.

Okay, we have arrived at the final leg of our journey, sections six and seven.

We are moving from inflammation and genetics to neoplasia, the lumps and bumps.

Soft tissue and peripheral nerve tumors.

Yeah, this section's all about classification.

The text organizes them by the type of tissue they resemble.

Fat, fiber, muscle, or nerve.

Let's start with fat, adipose tumors.

The benign version is the lipoma.

The text calls this the most common soft tissue tumor.

These are those squishy, mobile lumps people get on their back or neck.

Yeah, usually subcutaneous.

They're made of mature fat cells that look just like normal fat under the microscope, but they are contained in a lump.

It's usually just a cosmetic annoyance.

But then we have the malignant version, liposarcoma.

This is the most common adult sarcoma.

It tends to be in deep tissues, like the thigh or the retroperitoneum, which is the space behind the abdominal cavity.

And how do we tell them apart under the microscope?

This seems like a crucial distinction.

It's everything.

The hallmark of liposarcoma is the presence of the lipoblast.

Describe a lipoblast for us.

So a normal, mature fat cell has one big clear vacuole of fat that pushes the nucleus flat against the side.

A lipoblast is primitive.

It has multiple small vacuoles.

I see.

And these little bubbles push against the nucleus and create indentations, making the nucleus look scalloped.

If you see a scalloped nucleus with multiple vacuoles, that's a lipoblast, that's sarcoma.

Okay, lipoma equals mature fat.

Liposarcoma equals lipoblasts with scalloped nuclei.

Got it.

Perfect.

And this category, fibrous tumors.

First, the dermatofibroma.

This is benign.

It's a small, red, tender nodule on the skin.

The text mentions it is a spindle cell proliferation in the dermis.

Pretty straightforward.

Then there's this weird intermediate category, fibromatosis.

The text calls it non -neoplastic but proliferative.

What does that mean?

It occupies a gray area, doesn't metastasize, it doesn't spread to other organs, but it is locally very aggressive.

It invades muscle and tissue like a weed.

It's really hard to cut out completely.

The text divides these into superficial and deep.

The superficial ones include palmar fibromatosis, which you might know is Dupuitrin contracture in the hand, and penile fibromatosis or perine disease.

And the deep ones?

Those are called desmoids.

They can occur in the abdominal wall.

The text notes a specific association.

Abdominal desmoids in women often occur during or after pregnancy.

And there's a syndrome association mentioned as well.

Yes, Gardner syndrome.

If you see intra -abdominal fibromatosis, you need to be thinking about Gardner syndrome, which involves colon polyps and osteomas.

Now the truly malignant fibrous tumor, fibrosarcoma.

This is a malignancy of fibroblasts, common in the thigh or upper limb.

And figure 28 to four shows the classic histology.

Describe that pattern.

The text uses a specific word.

Herringbone.

It's this beautiful but deadly zigzag pattern of spindle cells.

They interlock like the weave of a tweed jacket or the bones of a fish.

Herringbone equals fibrosarcoma, and one more in this group,

undifferentiated pleomorphic sarcoma.

Right, this used to be called malignant fibrous histiocytoma or MFH.

It's the most common soft tissue sarcoma in older adults.

It's large, aggressive, and the microscopic pattern is storiform.

Storiform.

It means cartwheel -like.

The spindle cells swirl around a central point, like the spokes of a wheel.

Okay, moving to muscle tumors.

We can skip the skeletal muscle tumors, the rhabdomyomas, as the text refers us to other chapters.

So let's look at smooth muscle tumors.

Leomaeoma is the benign one.

Most people know these as fibroids in the uterus.

Exactly, benign, smooth muscle.

The text notes they can also occur in the skin, arising from the erector pili muscles, the little muscles that give you goosebumps.

And the malignant version,

leomaeosarcoma.

These are aggressive tumors, often in the retroperitonium of older women.

What is the microscopic buzzword for smooth muscle cancer?

How do we recognize it?

Cigar -shaped nuclei.

The nuclei are elongated but blunt -ended, not pointy like fibroblasts.

They look like little cigars.

One last soft tissue tumor before we hit the nerves,

synovial sarcoma.

This is a tricky name because it doesn't actually come from synovial cells, but it occurs near joints, often the knee, typically in young adults.

What is unique about its histology?

It can be biphasic.

Biphasic meaning two phases, two cell types.

Exactly, it contains both epithelial cells, which form gland -like structures, and spindle cells.

Seeing those two distinct populations mixed together is highly characteristic of synovial sarcoma.

Also, the text notes calcification is common, which you might even see on an X -ray.

All right, finally, section seven, peripheral nerve sheath tumors.

These tumors arise from the cells that cover the nerve, the sheath cells.

We have benign and we have malignant.

The two benign ones are schwannoma and neurofibroma.

Differentiating these is a classic exam favorite.

Let's start with schwannoma.

Schwannomas are encapsulated, this is key.

They're contained in a true capsule that pushes the nerve fibers to the side.

So surgically, you can spare the nerve.

Often, yes, you can peel the tumor off the nerve.

Microscopically, they have a pattern of alternating dense areas called Antoni A and loose micsoid areas called Antoni B.

And the genetic association.

Neurofibromatosis type two, NF2.

Okay, now compare all of that to neurofibroma.

Neurofibromas are non -encapsulated.

They grow within the nerve fascicle.

They are part of the nerve.

So they entrap the nerve fibers.

Exactly, you can't just peel it off.

The nerve is embedded within the tumor.

Figure 28 to five in the book shows the microscopy.

Wavy, loose, or dense collagen bundles.

Kind of looks like shredded cabbage.

That's a good visual.

And the genetic association here.

Neurofibromatosis type one, NF1.

And finally, the malignant peripheral nerve sheath tumor or MPNST.

These are highly aggressive sarcomas.

They can arise on their own or from the transformation of a preexisting neurofibroma, especially in NF1.

They typically occur in large nerve trunks like the sciatic nerve.

Wow, we have covered the entire chapter.

We really have.

We went from the mitochondrial density of type I fibers through the T8 cell attacks of polymyositis, the receptor blockade of myasthenia gravis, the tragic deletions of Duchenne, the ascending paralysis of Guillain -Barre, and finally sorted through the histology of every major soft tissue tumor.

It's a lot of information, but I feel like seeing it laid out in this order,

physiology, inflammation, junction, genetics, tumors, it gives it a narrative structure.

It makes sense.

That's the key.

Pathology isn't random.

It's logical.

If you understand the structure and you understand the mechanism, the symptoms and the microscopic findings just fall into place.

And I think that wraps up our mission for today.

We hope this framework helps you master chapter 28.

Keep looking for those patterns.

The contrast between diseases is where the real understanding lies.

Thanks for listening.

This has been a production of the Last Minute Lecture Team.